Sutro Biopharma (STRO) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sutro Biopharma is the larger company by market cap ($243.1 million vs $240.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | STRO | VOGX |
|---|---|---|
| Share price | $14.66 | $16.16 |
| Market cap | $243.08M | $240.06M |
| 1-day change | +1.45% | -1.40% |
| YTD return | +26.71% | — |
| 1-year return | +74.52% | — |
| 5-year return | -92.28% | — |
| EPS (TTM) | $-17.28 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $43.85 | $38.41 |
| 52-week low | $7.15 | $12.95 |
| Distance from 52-week high | -66.57% | -57.93% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +222.17% | +240.35% |
| Average volume | 289.73K | 187.53K |
| Shares outstanding | 16.58M | 14.86M |
| Employees | 128 | 4 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Sutro Biopharma
STRO stock →Sutro Biopharma, Inc. operates as an oncology company.
Healthcare · Biotechnology · 128 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Healthcare · Biotechnology · 4 employees
STRO vs VOGX FAQ
Which is bigger, Sutro Biopharma or Vogenx?
Sutro Biopharma (STRO) is larger, with a market capitalization of $243.08M compared with $240.06M for Vogenx (VOGX).
Are Sutro Biopharma and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.